Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 4/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19370107 | 1.00 | MAPT (0.55) | MAPTRAB9ASMN1; SMN2MAOBL3MBTL1 | |
| SCHEMBL12530833 | 0.95 | MAPT (0.61) | MAPTRAB9ASMN1; SMN2MAOBL3MBTL1 | |
| SCHEMBL12459480 | 0.88 | L3MBTL1 (0.58) | MAPTRAB9ASMN1; SMN2MAOBL3MBTL1 | |
| SCHEMBL12452818 | 0.85 | MAPT (0.50) | MAPTRAB9ASMN1; SMN2MAOBL3MBTL1 | |
| SCHEMBL25040676 | 0.83 | L3MBTL1 (0.53) | MAPTRAB9ASMN1; SMN2MAOBL3MBTL1 | |
| SCHEMBL30274345 | 0.83 | L3MBTL1 (0.53) | MAPTRAB9ASMN1; SMN2MAOBL3MBTL1 | |
| SCHEMBL25144727 | 0.82 | SMN1; SMN2 (0.46) | MAPTSMN1; SMN2MAOBL3MBTL1HDAC7 | |
| SCHEMBL13256446 | 0.81 | RAB9A (0.60) | MAPTRAB9ASMN1; SMN2L3MBTL1TDP1 | |
| SCHEMBL29908236 | 0.81 | RAB9A (0.60) | MAPTRAB9ASMN1; SMN2L3MBTL1TDP1 | |
| SCHEMBL10337042 | 0.81 | MAPT (0.64) | MAPTRAB9ASMN1; SMN2L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118382435-A | 12/15-Lipoxygenase inhibitors | 总医院公司 | 2024-07-23 | — | — | CN | disclosed |